This is a StreetInsider.com Premium Only Page

(GMAB) – StreetInsider.com Reports

Apr 16, 2024 06:26 AM Genmab A/S (GMAB) Reports Q1 Net Sales of DARZALEX of $2.69B

Apr 3, 2024 05:41 AM Genmab A/S (GMAB) to Acquire ProfoundBio for $1.8B Cash

Mar 21, 2024 08:10 AM Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK1,860 at Citi

Mar 15, 2024 08:18 AM Genmab A/S (GMAB) Announces DKK 3.5B Share Buyback

Feb 26, 2024 07:55 PM Genmab (GMAB) FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab

Feb 23, 2024 05:07 AM BMO Capital Upgrades Genmab A/S (GMAB) to Outperform 'On Improved Outlook ex-Darzalex, Pipeline Optionality'

Feb 21, 2024 02:16 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,400 at RBC Capital

Feb 20, 2024 07:25 AM Genmab A/S (GMAB) PT Lowered to $50 at Truist Securities

Feb 20, 2024 06:15 AM Genmab A/S (GMAB) PT Lowered to $33.50 at Goldman Sachs

Feb 14, 2024 02:12 PM Genmab A/S (GMAB) Files Annual Report with the U.S. SEC

Feb 14, 2024 11:43 AM Genmab (GMAB) Announces Initiation of Share Buy-Back Program

Jan 29, 2024 06:44 AM Genmab A/S (GMAB) PT Raised to $50 at H.C. Wainwright

Jan 23, 2024 06:26 AM Genmab A/S (GMAB) Reports FY23 DARZALEX Sales of $9.74B

Jan 23, 2024 03:58 AM Genmab A/S (GMAB) Announces Decision in Arbitration Appeal under License Agreement with Janssen

Jan 22, 2024 10:22 AM Citi Downgrades Genmab A/S (GEN:DC) (GMAB) to Sell

Jan 17, 2024 12:08 PM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,800 at Barclays

Jan 9, 2024 06:45 AM Pfizer (PFE) and Genmab (GMAB) Reports TIVDAK sBLA Accepted for Priority Review by FDA

Dec 6, 2023 03:17 AM UBS Upgrades Genmab A/S (GEN:DC) (GMAB) to Buy

Dec 5, 2023 02:20 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,500 at JPMorgan

Nov 8, 2023 06:42 AM Genmab A/S (GMAB) PT Lowered to $49 at H.C. Wainwright

Nov 8, 2023 12:54 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK3,000 at Barclays

Oct 18, 2023 05:01 AM Exane BNP Paribas Starts Genmab A/S (GMAB) at Underperform

Oct 17, 2023 06:25 AM Genmab A/S (GMAB) Reports Q3 Net DARZALEX Sales of $2.5B

Oct 13, 2023 06:03 AM Genmab A/S (GMAB) PT Raised to $46 at BTIG

Sep 28, 2023 01:00 PM Genmab A/S (GMAB) PT Raised to $41.50 at Goldman Sachs

Sep 28, 2023 12:23 PM Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,808 at Goldman Sachs

Sep 25, 2023 05:55 AM Genmab A/S (GMAB) Announces EPKINLY Approved by Japan Ministry of Health, Labour and Welfare

Sep 6, 2023 02:56 AM RBC Capital Downgrades Genmab A/S (GEN:DC) (GMAB) to Sector Perform

Sep 5, 2023 05:35 AM Seagen (SGEN) and Genmab (GMAB) Report TIVDAK Met its Primary Endpoint of Improved Overall Survival

Aug 24, 2023 05:42 AM BTIG Starts Genmab A/S (GMAB) at Buy, 'Well Positioned in the Crowded Oncology Landscape'

Jul 14, 2023 03:45 AM HSBC Starts Genmab A/S (GEN:DC) (GMAB) at Buy

Jun 28, 2023 05:22 AM AbbVie (ABBV) and Genmab (GMAB) Report Positive Topline Results from Phase 1/2 EPCORE NHL-1 Trial

Jun 28, 2023 04:08 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,740 at Citi

Jun 22, 2023 07:01 AM Genmab A/S (GMAB) Announces Epcoritamab Added to National Comprehensive Cancer Network

May 31, 2023 02:43 AM UBS Starts Genmab A/S (GEN:DC) (GMAB) at Neutral

May 22, 2023 06:57 AM Genmab A/S (GMAB) PT Raised to $51 at H.C. Wainwright

May 19, 2023 12:34 PM Genmab (GMAB) EPKINLY Approved by FDA as First and Only Bispecific Antibody to Treat Adults with R/R Diffuse Large B-cell Lymphoma

May 16, 2023 06:52 AM Genmab A/S (GMAB) PT Raised to $47 at H.C. Wainwright

May 16, 2023 02:02 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK3,200 at JPMorgan

May 15, 2023 09:10 AM Key Biotech Events to Watch, Week of 5/15/2023

May 15, 2023 09:08 AM Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review

May 12, 2023 03:22 AM Morgan Stanley Starts Genmab A/S (GEN:DC) (GMAB) at Underweight

Apr 18, 2023 06:26 AM Genmab A/S (GMAB) Reports Q1 Net Sales of DARZALEX of $2.27B

Apr 17, 2023 05:32 AM Genmab A/S (GMAB) and argenx (ARGX) Partner to Advance Antibody Therapies in Immunology and Oncology

Mar 28, 2023 05:51 AM Genmab A/S (GMAB) Appoints Martine van Vugt as Chief Strategy Officer

Mar 9, 2023 03:25 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK3,400 at JPMorgan

Mar 2, 2023 06:34 AM Genmab A/S (GMAB) PT Lowered to $46 at H.C. Wainwright

Mar 1, 2023 08:20 AM Genmab A/S (GMAB) PT Lowered to $33 at Morgan Stanley

Feb 27, 2023 11:15 AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,750 at Deutsche Bank

Feb 22, 2023 11:13 AM Genmab (GMAB) Announces Initiation of Share Buy-Back Program